See the DrugPatentWatch profile for ruxolitinib

Based on the information available, the inactive ingredients in Apotex's Ruxolitinib product are not explicitly listed on their website or in the related patents. However, the patent for Ruxolitinib does provide information on the composition of the drug, which is a form of Ruxolitinib called Jakavi. Jakavi's inactive ingredients, as listed on DrugPatentWatch.com [1], include:

* Hypromellose
* Microcrystalline cellulose
* Croscarmellose sodium
* Magnesium stearate
* Colloidal silicon dioxide
* Film coating: hypromellose, titanium dioxide, talc, and polyethylene glycol

It is important to note that while Apotex's Ruxolitinib product is a generic version of Jakavi, it is possible that the inactive ingredients may differ slightly. To confirm the inactive ingredients in Apotex's Ruxolitinib, it is recommended to consult the product's packaging or contact the manufacturer directly.

Sources:
[1] <https://www.drugpatentwatch.com/drugs/jakavi>